Depo Provera Osteoporosis

Depo-Provera Blog Home
Archives
Category Index
Nationwide claims being brought by Depo Provera users.
Do I have a Depo-Provera Case?
Depo-Provera Lawsuits


Depo-Provera Blog Home : November 2004

Black Box Warning Added Concerning Long-Term Use of Depo-Provera Contraceptive Injection

The Food and Drug Administration (FDA) announced today that a "black box" warning, highlighting prolonged use may result in the loss of bone density, will be added to the labeling of Depo-Provera Contraceptive Injection, an established injectable drug approved for use in women to prevent pregnancy. http://www.fda.gov/bbs/topics/ANSWERS/2004/ANS01325.html



Depo-Provera: Evaluation of BMDensity and Total Body Ca Adolescent

Why are we jsut hearing about these probelms in Depo Provera, when it has been around so long and studies were completed long ago?

Fore example, see: ClinicalTrials.gov Identifier: NCT00139685


Purpose:
To evaluate and compare Bone Mineral Density (BMD) in adolescent Depo-Provera Contraceptive Injection (DP150CI) users during depo medroxyprogesterone acetate (DMPA) therapy and following discontinuation of DMPA.


Primary Outcomes: Changes in Bone Mineral Density in adolescent Depo-Provera Contraceptive Injection (DP150CI) users will be evaluated


Study start: April 1999; Study completion: September 1999


» June 2005

 


 

Home  |  Site Map  |  Disclaimer